[10 February 2014]
Products Affected - Description
Aquasol A, Hospira
50,000 units/mL, 1 mL ampule (NDC 61703-0418-07)
Reason for the Shortage
- Hospira is changing manufacturing sites from a 3rd party manufacturer to in-house manufacturing. This has caused a delay in production.
- Hospira is the sole manufacturer of vitamin A injection.
There are no presentations available.
Estimated Resupply Dates
Hospira has Aquasol A injection on back order and the company cannot estimate a release date.
February 10, 2014; November 12, 2013; September 4, 2013; June 10, 2013; March 5, 2013; December 31, 2012; October 31, 2012; September 19, 2012; June 5, 2012; March 22, 2012; January 31, 2012; December 2, 2011; October 6, 2011; August 23, 2011; June 23, 2011; April 29, 2011; March 29, 2011; March 14, 2011; January 27, 2011; December 27, 2010; November 29, 2010; November 23, 2010, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins